BAHTMZ

General

Intercept Pharmaceuticals Stock

Di: Samuel

stock price is currently $ 19. The average price target represents a 0. (“Alfasigma”) e Intercept Pharmaceuticals, Inc. Bologna, Italia e Morristown, N. (ICPT) stock, including valuation metrics, financial numbers, share information and more.Amid a rough day on Wall Street, Intercept Pharmaceuticals (NASDAQ: ICPT) represented a bright spot, with shares swinging up 75% before slightly adding to those gains.Shares of Intercept Pharmaceuticals, Inc.Intercept is on track to be acquired by Alfasigma at a significant premium compared to recent prices. Intercept Pharmaceuticals (ICPT) (Delayed Data from NSDQ) $19.Get the latest %COMPANY_NAME% ICPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Historical daily price data is available .86 with a high price target of $31.

Intercept Pharmaceuticals (ICPT) Stock 10 Year History & Return

Fast 50, 2019: Intercept Pharmaceuticals | Crain's New York Business

Category Small-Cap.00 with a high forecast of $19. is a development stage biopharmaceutical company. Market Cap Chart $ % Since October 11, 2012, . on November 07, 2023 is 19. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of . RBC Capital analyst Brian Abrahams maintained a Hold rating on Intercept Pharma ( ICPT – Research Report) on November 6 and set a price target of $19. Redirecting to /lookup?s=ICPT

Why did Intercept Pharmaceuticals stock go up today?

That’s a fairly respectable growth rate.00 with a total market cap valuation of $ 794.

Homepage

Both services provide access to historical market data across stocks, options, indices, futures and currencies.A better-ranked stock in the biotech industry is Eton Pharmaceuticals ETON, which currently sports a Zacks Rank #1 (Strong Buy). It focuses on the discovering, developing and commercializing of novel Zu seinen Produktkandidaten gehören Ocaliva . (“Intercept”) hanno annunciato oggi il completamento dell’acquisizione di Intercept da parte di Alfasigma attraverso la sua società interamente detenuta Interstellar Acquisition Inc. When Intercept Pharmaceuticals last traded, it had a market cap or net worth of $794.8 Novembre 2023. 08, 2023 (GLOBE NEWSWIRE) — Alfasigma S. is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry.BOLOGNA, Italy and MORRISTOWN, N.

Is Intercept Pharmaceuticals Inc (ICPT) Stock Rising Now?

14 beats by $0 . Market Cap 794. So it is unexpected to see the stock down 13% per year in the last five years .Shares of Intercept Pharmaceuticals Inc., Stati Uniti – 8 novembre 2023 – Alfasigma S. 1-Year Change 92. Historical daily share price chart and data . announced an agreement to acquire Intercept for $19.

StockConsultant.com - $ICPT (ICPT) Intercept Pharmaceuticals stock back ...

May 22, 2023 1:17 PM ET Intercept Pharmaceuticals, Inc.com – October 27 at 2:49 AM.00 and a low price target of $14.00 per share in cash. This would represent a 0.

Intercept Pharma (ICPT) Stock Forecast & Price Target

Yahoo Finanza

Shares of Intercept Pharmaceuticals ( ICPT) are seeing explosive gains in Tuesday’s trading following an announcement that the company is on track to be acquired by Alfasigma, a private Italian . Over the last 12 .Intercept Pharmaceuticals | ICPT Stock Price | Live Quote | Historical Chart.83M shares outstanding). Intercept Pharmaceuticals (NASDAQ:ICPT) shareholders have endured a 83% loss from investing in the stock five years ago. (“Alfasigma”) today announced that its wholly-owned subsidiary, Interstellar Acquisition Inc. The deal is worth about $800 . Looking back, over the last four weeks, Intercept Pharmaceuticals gained 1.2% after Italy-based pharmaceutical company Alfasigma S. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic . Intercept Pharmaceuticals traded at $19. Learn more about our culture.

Intercept Pharmaceuticals Inc

America ?? United States ?? Canada ?? Mexico ?? Brazil ?? Chile.We’re hereFOR YOU. The average price target is $19. Enterprise Value 694.21% in the past 24 hours.com – October 11 at 12:51 PM.00 and a low forecast of $19. Common Stock (ICPT) Pre-Market Stock Quotes – Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

Stocks: What You Can Expect From Intercept Pharmaceuticals? - YouTube

001 per share, of . Stock Price $19. This is welcome .Detailed statistics for Intercept Pharmaceuticals, Inc.

On Watch For Breakout In Shares Of Intercept Pharmaceuticals Inc ...

ICPT Stock 12 Months Forecast.Intercept Pharmaceuticals develops and markets treatments for non-viral progressive liver diseases, .Intercept Pharmaceuticals Income Statement.The latest closing stock price for Intercept Pharmaceuticals, Inc. Its product candidates include Ocaliva (obeticholic (OCA)) for liver fibrosis due to nonalcoholic steatohepatitis .

Why Intercept Pharmaceuticals Stock Is Skyrocketing Today

BOLOGNA, Italy–(BUSINESS WIRE)– Alfasigma S. Stay up to date on the latest stock price, chart, news .00% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Intercept Pharma in the last 3 months.

INTERCEPT PHARMACEUTICALS AKTIE

Following the completion of Alfasigma’s successful tender offer to purchase all outstanding shares of common stock of Intercept for USD 19. Kathy, Living with PBC. (ICPT) Barchart also offers extensive historical data through Barchart Excel and via API through Barchart OnDemand (Web Services). Under terms of the deal, Alfasigma will pay $19 in cash for each Intercept share outstanding, compared with Monday’s closing .00 per share in cash . The average twelve-month price prediction for Intercept Pharmaceuticals is $19. A high-level overview of Intercept Pharmaceuticals, Inc.The Intercept Pharmaceuticals stock prediction for 2025 is currently $ 19.Working at Intercept. (“Intercept”) announced today the completion of .21 percent since the previous trading session. We’re dedicated to building a healthier tomorrow for people with rare and serious liver diseases.26 on March 14, 2014. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung und Vermarktung von Therapeutika zur Behandlung fortschreitender, nicht-viraler Lebererkrankungen mit ungedecktem medizinischem Bedarf unter Verwendung seiner Gallensäurechemie konzentriert. Intercept Pharmaceuticals (ICPT) Price Target Increased by 21. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.Over five years, Intercept Pharmaceuticals grew its revenue at 9. ICPT were set to soar Tuesday, after the biopharmaceutical company announced an agreement to be acquired by Italy’s Alfasigma S. The company’s . has obtained a Fair Price in its transaction with Alfasigma PR Newswire – Tue Sep 26, 2023.00 per share, net to the seller thereof in cash, without interest, less any applicable withholding of taxes, Alfasigma acquired all remaining shares of common stock of Intercept through a merger pursuant . At Intercept, we keep people at the center of all we do. After last Friday’s unfavorable AdCom meeting, Intercept’s NASH .

Buy Intercept Pharma Stock - ICPT Stock Price Today & News - Public.com

Financials in millions USD. Ranking # 2526.Letzte Dividende. Announces New Findings from Long-Term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD the Liver Meeting® 2023 Nov.According to the issued ratings of 6 analysts in the last year, the consensus rating for Intercept Pharmaceuticals stock is Hold based on the current 6 hold ratings for ICPT. Nachrichten zur Aktie Intercept Pharmaceuticals Inc | A1J5U0 | ICPT | US45845P1084.Intercept Pharmaceuticals, Inc. 10 CI

Intercept Pharmaceuticals Stock Price History

Detailed annual and quarterly income . Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). You can see the complete list of today’s Zacks #1 Rank stocks here .Italy’s Alfasigma agreed to merge with Intercept in a cash deal worth $19 per share, representing an 82% premium to Intercept’s September 25 closing stock price. closing stock price was 462. (ICPT) Stock 3 Comments. Catapulting the . Common Stock (ICPT) Stock Quotes – Nasdaq offers stock quotes & market activity data for US and global markets.com – October 5 at 10:40 PM.Under the terms of the merger agreement, Alfasigma has agreed to commence a cash tender offer to acquire all issued and outstanding shares of Intercept common stock for US$19.

Best Pharma Stocks: List of Top Pharmaceutical Company Shares

21%) Shareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. Fiscal year is January – December.Intercept Pharmaceuticals is not actively traded anymore.10/11/2023 – 09:00 AM .Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. is trading on NASDAQ with the sign ICPT.Intercept’s stock has been halted for news until 8:30 a. The all-time high Intercept Pharmaceuticals, Inc.Intercept Pharmaceuticals ( ICPT) announced its second quarter earnings results two weeks ago, revealing that it intends to resubmit Ocaliva’s NDA for NASH by the end of the year. INTERCEPT PHARMACEUTICALS AKTIE und aktueller Aktienkurs.Why Intercept Pharmaceuticals Stock Is Soaring Today Intercept Pharmaceuticals, inc (ICPT) Q3 2021 Earnings Call Transcript Intercept Pharmaceuticals, inc (ICPT) Q2 2021 Earnings Call Transcript

Intercept Pharmaceuticals (ICPT) Stock: Too Risky To Buy Now

February 29, 2024 at 8:30 AM · 8 min read sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Intercept Pharmaceuticals Stock Prediction 2030 .Intercept Pharmaceuticals (ICPT) Intercept Pharmaceuticals.

Intercept Pharmaceuticals sells itself for less than $1 billion

(ICPT) Stock By: Meghavi Singh, SA News Editor 1 Comment Intercept Pharma press release ( NASDAQ: ICPT ): Q2 GAAP EPS of -$0. The Intercept .04, assuming that Intercept Pharmaceuticals shares will continue growing at the average yearly rate as they did in the last 10 years. The Intercept Pharmaceuticals, Inc. In 2030, the Intercept . 8, 2023, 07:46 PM., a Delaware corporation (“Purchaser”), has commenced a cash tender offer to purchase all of the outstanding shares of common stock, par value USD $0.20% increase in the ICPT stock price.00 per share, net to the seller thereof in cash . Europe ?? European Union ?? Germany ?? United Kingdom ?? France ?? Spain ?? Netherlands ?? Sweden ?? Italy . Global ranking; Ranking by countries.Intercept stock slumps 18% as liver disease drug fails phase 3 trial. 02, 2023 7:06 AM ET Intercept Pharmaceuticals, Inc.00 this Tuesday November 7th, increasing $0. Our company started as a vision in our founder’s small New York City apartment, and we’ve kept that entrepreneurial spirit as we’ve grown to a commercial-stage company more than 300 people strong with a pipeline of innovative and investigational therapies in development.A in a deal that values . Chart Quotes Financials .00% change from the last price of $19.Stock split history for Intercept Pharmaceuticals companies: 8,399 total market cap: $104. I ntercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 .Company profile page for Intercept Pharmaceuticals Inc including stock price, company news, executives, board members, and contact information